VertiFlex Announces FDA Approval of Superion Interspinous Spacer System

By: Mark Speegle

(May 26, 2015) VertiFlex, Inc., announced that it has been granted pre-market approval by the FDA for its minimally invasive treatment of lumbar spinal stenosis, the Superion Interspinous Spacer System.  This approval comes after a successful 470 patient IDE study of the Superion system.  VertiFlex’s press release highlighted the following results from the IDE study:

  • Largest, most robust IDE device trial for moderate lumbar spinal stenosis
  • Superion demonstrated clinical success of >80% in all major components of the composite primary endpoint at 24 months, maintaining durability of effect through 36 months
  • Superion patients exhibited similar leg pain improvement, as measured by VAS, compared to published literature on open surgical decompression
  • Healthcare economic data was captured, demonstrating Superion’s cost-effective equivalency to open surgical decompression

The press release also notes that Superion has already been successfully implanted in more than 2,000 patients internationally.  VertiFlex was founded in 2005 and is based in San Clemente, CA.

Leave a Reply

By using this blog, you agree and understand that no information is being provided in the context of any attorney-client relationship. You further agree and understand that nothing herein is intended to be legal advice. This blog is solely informational in nature, and is not intended as, and should not be used as, a substitute for competent legal advice from a retained and licensed attorney in your state. Knobbe Martens LLP makes no representations or warranties as to the accuracy, completeness, timeliness or availability of the information in this blog. Knobbe Martens LLP will not be liable for any injury or damages relating to your use of, or access to, any such information. Knobbe Martens LLP undertakes no obligation to correct or update information on this blog, which may be incorrect or become incorrect or out of date over time. Knobbe Martens LLP reserves the right to alter or delete content or information on the blog at any time. This blog contains links and references to other websites and publications that you may find of interest. Knobbe Martens LLP does not control, promote, endorse or otherwise have any affiliation with any other websites or publications unless those websites or publications expressly state such an affiliation. Knobbe Martens LLP further has no responsibility for, and makes no representations regarding, the content, accuracy or any other aspect of the information in such websites or publications.